a day ago
EXEL
AnalystsYaron WerberYaron Werber's Stock Forecasts
AnalystsYaron Werber
Sectors:
Industries:
Analyst Ranking
Top 21%
#1137 out of 5550 analysts
Average Return
+8.14%
Win Rate
53%32 out of 60
Risk vs Reward
Poor
Good
Yaron Werber's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Forte Biosciences IncFBRX | +114.29% | $14.70 | $31.50 | 2025-01-21 - 2026-01-21 | Strong Buy |
Zymeworks IncZYME | +99.84% | $12.43 | $24.84 | 2025-05-20 - 2026-05-20 | Strong Buy |
Genmab AGMAB | +97.78% | $28.85 | $57.06 | 2026-07-22 - 2026-10-30 | Strong Buy |
Beone Medicines LtdONC | +93.13% | $195.45 | $377.47 | 2024-11-13 - 2025-11-12 | Strong Buy |
Exelixis IncEXEL | +78.56% | $21.93 | $39.15 | 2024-05-01 - 2025-04-30 | Strong Buy |
Yaron Werber Analyst Color
Get additional color on Yaron Werber's coverage of popular stocks
6 days ago
GMAB
2 months ago
ROIV
3 months ago
ASND
Yaron Werber's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Exelixis IncEXEL | 5 | Strong Buy | $76.00 | +9.53% | Maintains | a day ago |
Genmab AGMAB | 3 | Strong Buy | $52.00 | -8.87% | Maintains | 6 days ago |
Foghorn Therapeutics IncFHTX | 1 | Hold | N/A | N/A | Downgrades | a month ago |
Roivant Sciences LtdROIV | 3 | Strong Buy | $55.00 | +49.01% | Maintains | 2 months ago |
Ultragenyx Pharmaceutical IncRARE | 4 | Strong Buy | $18.00 | +11.80% | Maintains | 2 months ago |
Ascendis Pharma AASND | 7 | Strong Buy | $341.00 | +35.71% | Maintains | 3 months ago |
Legend Biotech CorpLEGN | 5 | Hold | $24.00 | +10.96% | Maintains | 3 months ago |
Beone Medicines LtdONC | 7 | Strong Buy | $454.00 | +22.59% | Maintains | 3 months ago |
Amgen IncAMGN | 6 | Strong Buy | $452.00 | -3.01% | Maintains | 3 months ago |
Ionis Pharmaceuticals IncIONS | 4 | Strong Buy | $108.00 | +148.16% | Reiterates | 5 months ago |
Jasper Therapeutics IncJSPR | 2 | Hold | N/A | N/A | Downgrades | 6 months ago |
Biontech SeBNTX | 6 | Hold | $94.00 | +6.61% | Maintains | 8 months ago |
Rapt Therapeutics IncRAPT | 2 | Hold | N/A | N/A | Downgrades | 9 months ago |
Vor Biopharma IncVOR | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 10 months ago |
Argenx SeARGX | 4 | Strong Buy | $1,146.00 | N/A | Maintains | a year ago |
Alector IncALEC | 1 | Hold | N/A | N/A | Downgrades | a year ago |
Zymeworks IncZYME | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | a year ago |
Springworks Therapeutics IncSWTX | 1 | Hold | $47.00 | N/A | Downgrades | 2 years ago |
Forte Biosciences IncFBRX | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Dianthus Therapeutics IncDNTH | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Septerna IncSEPN | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Upstream Bio IncUPB | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Stoke Therapeutics IncSTOK | 1 | Strong Buy | N/A | N/A | Upgrades | 3 years ago |
Immuneering CorpIMRX | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
2seventy Bio IncTSVT | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Celldex Therapeutics IncCLDX | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Generation Bio CoGBIO | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Kyntra Bio IncKYNB | 1 | Hold | $625.00 | N/A | Maintains | 4 years ago |
Instil Bio IncTIL | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Bluebird Bio IncBLUE | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Orchard Therapeutics PLCORTX | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Io Biotech IncIOBTQ | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Acceleron Pharma IncXLRN | 1 | Hold | $180.00 | N/A | Downgrades | 5 years ago |
Dicerna Pharmaceuticals IncDRNA | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Nuvation Bio IncNUVB | 1 | Buy | N/A | N/A | Initiates Coverage On | 6 years ago |
Regeneron Pharmaceuticals IncREGN | 1 | Buy | $565.00 | N/A | Maintains | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.